|
RAB27A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.727600E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.697700E-02 |
| Normal-vs-Stage2 |
3.817600E-01 |
| Normal-vs-Stage3 |
8.460300E-03 |
| Normal-vs-Stage4 |
3.994400E-01 |
| Stage1-vs-Stage2 |
3.081000E-01 |
| Stage1-vs-Stage3 |
3.449200E-01 |
| Stage1-vs-Stage4 |
3.702600E-01 |
| Stage2-vs-Stage3 |
1.421750E-01 |
| Stage2-vs-Stage4 |
9.872400E-01 |
| Stage3-vs-Stage4 |
1.912210E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.754100E-02 |
| Normal-vs-AfricanAmerican |
5.129800E-02 |
| Normal-vs-Asian |
5.991200E-01 |
| Caucasian-vs-AfricanAmerican |
4.286800E-01 |
| Caucasian-vs-Asian |
8.370800E-01 |
| AfricanAmerican-vs-Asian |
6.635600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.319700E-02 |
| Normal-vs-Female |
1.365420E-01 |
| Male-vs-Female |
4.294800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.343000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.742300E-02 |
| Normal-vs-Age(61-80Yrs) |
2.369700E-02 |
| Normal-vs-Age(81-100Yrs) |
1.370100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.158800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.438200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.969400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.899800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.233600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.965000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.054000E-02 |
| Normal-vs-Grade 2 |
6.832500E-02 |
| Normal-vs-Grade 3 |
1.772440E-02 |
| Normal-vs-Grade 4 |
1.847210E-01 |
| Grade 1-vs-Grade 2 |
3.115000E-01 |
| Grade 1-vs-Grade 3 |
6.701400E-01 |
| Grade 1-vs-Grade 4 |
2.750400E-01 |
| Grade 2-vs-Grade 3 |
4.853000E-01 |
| Grade 2-vs-Grade 4 |
7.238400E-01 |
| Grade 3-vs-Grade 4 |
4.135200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.828300E-02 |
| Normal-vs-ccB subtype |
6.765700E-02 |
| ccA subtype-vs-ccB subtype |
7.549400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.673600E-02 |
| Normal-vs-N1 |
8.713400E-01 |
| N0-vs-N1 |
4.235200E-01 |
|
|
